Elsamadicy, A. A., Farber, S. H., Chongsathidkiet, P., Kemeny, H., Woroniecka, K., Cui, X., … Fecci, P. (2017). TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE. In Neuro-Oncology (Vol. 19, pp. vi264–vi265). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/nox168.1085

Elsamadicy, Aladine A., S Harrison Farber, Pakawat Chongsathidkiet, Hanna Kemeny, Karolina Woroniecka, Xiuyu Cui, Ian Dunn, and Peter Fecci. “TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE.” In Neuro-Oncology, 19:vi264–65. Oxford University Press (OUP), 2017. https://doi.org/10.1093/neuonc/nox168.1085.

Elsamadicy AA, Farber SH, Chongsathidkiet P, Kemeny H, Woroniecka K, Cui X, et al. TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE. In: Neuro-Oncology. Oxford University Press (OUP); 2017. p. vi264–5.

Elsamadicy, Aladine A., et al. “TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE.” Neuro-Oncology, vol. 19, no. suppl_6, Oxford University Press (OUP), 2017, pp. vi264–65. Crossref, doi:10.1093/neuonc/nox168.1085.

Elsamadicy AA, Farber SH, Chongsathidkiet P, Kemeny H, Woroniecka K, Cui X, Dunn I, Fecci P. TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE. Neuro-Oncology. Oxford University Press (OUP); 2017. p. vi264–vi265.